Skip to main content
×
Login
Submit a Manuscript
Home
Journal
Current Issue
Archive
For Authors
Column Series
Research & Insight
Special Reports
Subscribe
Resources
Biosimilars Excellence Forum
Blogs
Expert Insights
Latest News
Mantle Cell Lymphoma Excellence Forum
Pathways Beyond Oncology
Topics
Comparative Effectiveness Research
Cost-Effectiveness Research
COVID-19 Updates
Guideline Updates
Health Economics and Outcomes Research
Health Technology
Real-World Data
Reimbursement
Value-Based Care
Specialties
Acute Lymphoblastic Leukemia
Acute Myeloid Leukemia
B-Cell Lymphoma
Biosimilars
Bladder Cancer
Breast Cancer
CAR-T Therapies
Chronic Lymphocytic Leukemia
Chronic Myeloid Leukemia
Colorectal Cancer
Diffuse Large B-Cell Lymphoma
Follicular Lymphoma
Gastrointestinal Cancer
Genitourinary Cancer
Gynecologic Cancer
Head and Neck Cancer
Immuno-Oncology
Kidney Cancer
Liver Cancer
Lung Cancer
Mantle Cell Lymphoma
Melanoma
Multiple Myeloma
Non-Small Cell Lung Cancer
Ovarian Cancer
Pancreatic Cancer
Prostate Cancer
Skin Cancer
Supportive Care
Conferences
Oncology Clinical Pathways Congress
ASCO Gastrointestinal Cancers Symposium
ASCO Genitourinary Cancers Symposium
ASH Annual Meeting and Exposition
Oncology CME
About
About Us
Contact
News
News
Variation in Treatment Planning of Radiation Therapy Procedures in the United States
February 19, 2021
Study suggests provider characteristics, like gender and geographic region may play a role in predicting treatment planning of radiation oncology procedures.
News
Variation in Treatment Planning of Radiation Therapy Procedures in the United States
February 19, 2021
Study suggests provider characteristics, like gender and geographic region may play a role in predicting treatment…
News
Acalabrutinib Improves PFS and OS Over Other First-Line Regimens in CLL
February 17, 2021
Acalabrutinib demonstrated favorable PFS and OS compared with standard first-line treatments for CLL, according to a…
News
Higher Out-of-Pocket Costs Associated With Decreased TKI Adherence in NSCLC
February 15, 2021
Higher out-of-pocket costs for TKIs are associated with decreased therapy adherence among patients with EGFR- and ALK-…
News
Cost-Sharing Patterns for PARP Inhibitor Therapy in Ovarian Cancer
February 13, 2021
Results from a single-center study show payers incur the bulk of monthly PARP inhibitor cost for ovarian cancer.
News
Cost-Effectiveness of Selective Internal Radiotherapy vs Sorafenib in HCC
February 11, 2021
Compared with selective internal radiotherapy, sorafenib is not unlikely cost-effective for HCC in the United States.
News
Clinician- vs Patient-Reported Performance Status for Predicting Patient Outcomes
February 11, 2021
Study results show both clinician- and patient-reported performance status are useful for predicting morbidity and…
News
Predictive Model for at Home Care Among Patients With Solid-Tumor Malignancies
February 09, 2021
Researchers developed a predictive model for identifying admissions of patients with cancer who were potentially…
News
Targeted Genetic Testing Cost-Effective for Breast and Ovarian Cancer
February 08, 2021
Targeted BRCA or multiple gene screening is cost-effective for preventing breast and ovarian cancer, according to a…
News
Health Care Spending for High-Resource Patients With Prostate Cancer
February 01, 2021
Study findings show 5% of men diagnosed with prostate cancer accounted for 26% of the total cost of care for all men…
News
DRd Improves PROs Compared With Rd for Newly Diagnosed MM
February 01, 2021
Daratumumab, lenalidomide, and dexamethasone (DRd) yielded faster and sustained clinically meaningful improvements in…
Pagination
Current page
1
Page
2
Page
3
Page
4
Page
5
Page
6
Page
7
Page
8
Page
9
…
Next page
››
Last page
Last »
Stay in the know.
Journal of Clinical Pathways Newsletter
Back to Top